At Signant, we know you navigate many challenges in your vaccine programs: From large and globally dispersed participant pools to expedited schedules, multiphase designs, extended participant follow-up periods, and critical data management needs, you need a partner with appropriate solutions and experience.
Whether you’re developing new vaccines for COVID-19, RSV, CMV, Chikungunya, Lyme’s disease, hantavirus, or other infectious diseases, leverage our comprehensive ecosystem of evidence generation solutions and scientific services to accelerate and streamline clinical development processes while improving the quality and reliability of endpoint data.
PROOF AT THE SPEED OF LIFE
Accelerated vaccine development,
uncompromised
evidence quality
When a sponsor requested our services for a rapidly implemented phase I/II/III trial, Signant launched a 44,000-participant, global vaccine study involving 150 sites in seven countries - in just five weeks. Signant was the only partner prepared with the solutions, global reach, and resources to meet the protocol’s challenges, helping the sponsor achieve EUA in record time.
Proven results under pressure
Our solutions are better together
UNLOCK THE FULL VALUE OF SIGNANT SMARTSIGNALS
eCONSENT
RTSM
eCOA
Telemedicine
Whether your vaccine study is traditional, virtual, or a combination, take advantage of these solutions individually or use them together for a fully optimized end-to-end experience that addresses participant, site, and sponsor/CRO needs:
Patient Concierge
Rapidly implement eConsent the way that best matches your trial. From a rapid and cost-effective, PDF-based option to a rich multimedia solution, we’ll help you find the ideal eConsent model to match your study’s needs.
Our rapid deployment RTSM system flexibly adapts to the complex needs of vaccine studies such as: dynamic adjustment of site supply strategies to optimize medication distribution when recruitment is rapid or variable and enabling
multi-patient vial usage.
Collect high quality primary safety data using our proprietary, ready-built reactogenicity diary on either provisioned or bring-your-own devices.
Dosing-specific completion windows and built-in
alerts keeps PRO data completion on track, and data management services allow for timely interim
analyses where needed.
Connect participants to study teams to improve safety and reduce unnecessary site visits, an especially helpful tool for long-term follow up assessments.
Keep participants engaged and on track during long follow-up periods, encouraging study visit attendance
and participant retention.
